Medicare Enrolled
Dr. Vinit Mehrotra, MD
Neurology · Fort Worth, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mehrotra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehrotra? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mehrotra
Dr. Vinit Mehrotra is a neurology in Fort Worth, TX, with 19 years in practice. Based on federal Medicare data, Dr. Mehrotra performed 1,087 Medicare services across 750 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mehrotra received a total of $15,533 from 90 pharmaceutical and/or device companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mehrotra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 28% volume in TX$ $15,533 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,087
Medicare services
Top 28% in TX for neurology
750
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~57 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 259 | $90 | $164 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 247 | $25 | $60 |
| Initial hospital admission, high complexity | 94 | $135 | $387 |
| Hospital follow-up visit, high complexity | 64 | $93 | $195 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 61 | $35 | $98 |
| New patient office visit, complex (60-74 min) | 54 | $167 | $350 |
| Office visit, established patient, complex (40-54 min) | 53 | $136 | $219 |
| Measurement of brain wave activity (eeg), awake and drowsy | 43 | $302 | $550 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 41 | $77 | $144 |
| Hospital follow-up visit, moderate complexity | 37 | $62 | $142 |
| Needle measurement of electrical activity in arm or leg muscles, 2 extremities | 34 | $63 | $315 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 31 | $92 | $255 |
| Office visit, established patient (20-29 min) | 24 | $62 | $112 |
| Measurement of brain wave activity (eeg), in coma or asleep | 18 | $44 | $150 |
| New patient office visit (45-59 min) | 14 | $124 | $247 |
| Nerve conduction, 7-8 studies | 13 | $138 | $296 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,533
Total received (2018-2024)
Avg $2,219/year across 7 years
Top 20% in TX for neurology
90
Companies
944
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,473 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,924
2023$2,306
2022$2,353
2021$1,869
2020$1,736
2019$1,874
2018$2,472
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,685
Novartis Pharmaceuticals Corporation
$1,253
UCB, Inc.
$1,017
Biogen, Inc.
$1,017
ACADIA Pharmaceuticals Inc
$724
Teva Pharmaceuticals USA, Inc.
$658
Genentech USA, Inc.
$645
Supernus Pharmaceuticals, Inc.
$555
AbbVie Inc.
$448
Neurocrine Biosciences, Inc.
$400
Amgen Inc.
$377
Eisai Inc.
$375
Allergan, Inc.
$374
Sunovion Pharmaceuticals Inc.
$329
Alexion Pharmaceuticals, Inc.
$268
Lundbeck LLC
$265
Lilly USA, LLC
$248
Allergan Inc.
$206
SK Life Science, Inc.
$206
GENZYME CORPORATION
$197
PFIZER INC.
$186
Grifols USA, LLC
$180
CSL Behring
$169
Upsher-Smith Laboratories LLC
$162
EMD Serono, Inc.
$159
UPSHER-SMITH LABORATORIES LLC
$152
Kyowa Kirin, Inc.
$147
Acorda Therapeutics, Inc
$146
GE HealthCare
$136
Merz Pharmaceuticals, LLC
$132
ARGENX US, INC.
$131
JAZZ PHARMACEUTICALS INC.
$117
ARBOR PHARMACEUTICALS, INC.
$116
Adamas Pharmaceuticals, Inc.
$115
Boston Scientific Corporation
$112
GE HEALTHCARE
$105
Janssen Pharmaceuticals, Inc
$92
Amneal Pharmaceuticals LLC
$91
AbbVie, Inc.
$90
Nevro Corp.
$87
Alnylam Pharmaceuticals Inc.
$74
Avanir Pharmaceuticals, Inc.
$70
Promius Pharma LLC
$70
Horizon Therapeutics plc
$69
Abbott Laboratories
$65
Takeda Pharmaceuticals U.S.A., Inc.
$59
Janssen Research & Development, LLC
$57
PORTOLA PHARMACEUTICALS, LLC
$55
Ceribell, Inc.
$54
MITSUBISHI TANABE PHARMA AMERICA, INC.
$52
PORTOLA PHARMACEUTICALS, INC.
$52
Greenwich Biosciences, Inc.
$52
TG Therapeutics, Inc.
$51
Aucta Pharmaceuticals, Inc.
$48
EISAI INC.
$46
Biohaven Pharmaceuticals, Inc.
$45
Aprecia Pharmaceuticals, LLC
$39
AstraZeneca Pharmaceuticals LP
$38
BOSTON SCIENTIFIC CORPORATION
$37
Vanda Pharmaceuticals Inc.
$37
Almatica Pharma LLC
$37
Corium, LLC
$34
ANI Pharmaceuticals, Inc.
$33
Zyla Life Sciences, Inc.
$30
Life Molecular Imaging Ltd
$30
GE Healthcare
$29
Biocodex, Inc.
$25
Piramal Imaging Limited
$23
Ultragenyx Pharmaceutical Inc.
$23
Jazz Pharmaceuticals Inc.
$21
Octapharma USA, Inc.
$21
Medtronic USA, Inc.
$19
US WorldMeds, LLC
$18
Impax Laboratories, Inc.
$18
Azurity Pharmaceuticals, Inc.
$18
Mallinckrodt Enterprises LLC
$17
AQUESTIVE THERAPEUTICS, INC.
$16
Currax Pharmaceuticals LLC
$16
Neurelis, Inc.
$16
Medtronic Vascular, Inc.
$15
Celgene Corporation
$15
Medtronic, Inc.
$15
ASSERTIO THERAPEUTICS, Inc.
$15
Vertical Pharmaceuticals, LLC
$15
NOVARTIS PHARMACEUTICALS CORPORATION
$13
Cala Health, Inc.
$13
Mylan Pharmaceuticals Inc.
$12
IMPEL PHARMACEUTICALS INC.
$12
Egalet US Inc
$11
OWP Pharmaceuticals, Inc.
$11
Top 3 companies account for 25.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · ALLODERM · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CALA TRIO · COPAXONE · Confirm Rx · DAYBUE · DIACOMIT · DUOPA · Duopa · EMGALITY · EPIDIOLEX · Edarbi · Enspryng · Epidiolex · FORTEO · Fintepla · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEADPOINT · LEMTRADA · LEQEMBI · LINQ II · LYRICA · Lamotrigine Starter Kit · Leqembi · MAYZENT · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Omnia · Ongentys · PANZYGA · PLEGRIDY · POCKET EEG DEVICE · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RYTARY · Rebif · Reveal LINQ · Rystiggo · SKYCLARYS · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Senza · Skyclarys · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WATCHMAN Access System · XARELTO · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1,429 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
80
Per 100K population
3.7
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mehrotra is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), and high industry engagement (low-engagement, top 20%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mehrotra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mehrotra performed 259 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehrotra receive payments from pharmaceutical companies?
Yes. Dr. Mehrotra received a total of $15,533 from 90 companies across 944 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehrotra's costs compare to other neurologys in Fort Worth?
Dr. Mehrotra's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehrotra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Fort Worth
Browse neurologys in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in TX
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in TX
Which TX neurologys receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology